Thursday, October 29, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Copper turns designer peptides into selective cancer-cell killers in lab tests

Researchers report that binding copper(II) ions to one of two designer peptides containing non-canonical amino acids markedly increased its cytotoxic activity against cancer cells…

PR
By Priya Raman · Science Reporter
Oct 29 05:52 ETSource: Bioengineer.org

From the source

Copper turns designer peptides into selective cancer-cell killers in lab tests

Researchers report that binding copper(II) ions to one of two designer peptides containing non-canonical amino acids markedly increased its cytotoxic activity against cancer cells in vitro, with no loss of viability in normal human dermal fibroblasts at the tested concentrations.

Read at bioengineer.org
PeptiPrescribed peptides from $99/moSee all →